Stop HIV and AIDS Now
Roll out treatment as prevention
The Lancet column calls for immediate, collaborative expansion of global HIV strategy
The Lancet, a leading global medical journal, recently published an editorial comment that emphasises the critical role of expanding access to HIV treatment under a "Treatment as Prevention" strategy to stop the HIV pandemic. The publication of the editorial comment coincided with the opening of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) in Rome, Italy from July 17-20. The commentary – by Dr. Julio Montaner, director of the British Columbia Centre for Excellence in HIV/AIDS (BC-CfE) and Past President of the International AIDS Society (IAS) – strongly reinforced the view that the benefits of highly active antiretroviral therapy (HAART) extend beyond the remarkable effectiveness of the treatment to prevent the onset of AIDS and prolong life, to dramatically reduce HIV transmission. Based on HAART's effectiveness in reducing transmission, Dr. Montaner called on the international community to support an immediate and expanded roll out of HAART under the Treatment as Prevention strategy, as pioneered by the BC-CfE in British Columbia, Canada. "Treatment as Prevention is one of the most important and promising additions to the range of prevention strategies available to us today," said Dr. Elly Katabira, President of the IAS and Chair of IAS 2011. Current HIV treatment reduces the level of HIV in the blood to undetectable levels, thus improving the health of HIV-positive individuals. At the same time, the treatment decreases the level of HIV in sexual fluids to undetectable levels, thereby reducing the likelihood of HIV transmission by over 90 per cent. "The evidence is clear: treatment conclusively prevents morbidity, mortality and transmission," said Dr. Montaner. "We now have ample and compelling evidence that treatment prevents HIV transmission during pregnancy and breastfeeding, as well as in sexual and injection drug use settings. The challenge remains to optimise the impact of this valuable intervention. Failure to do so is not an option." A recent study by the US National Institutes of Health (NIH) reported that immediate use of HAART led to a 96% decrease in the risk of HIV transmission among heterosexual couples where one partner is HIV positive. "These results are a real scientific breakthrough and a game changer in the response to HIV," said Michel Sidibé, Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS). The Treatment as Prevention model has been embraced by UNAIDS and the World Health Organisation within the Treatment 2.0 initiative, announced last year as a central pillar of the global strategy to respond to HIV. In February 2011, in consultation with the BC-CfE and the Chinese Centre for Disease Control and Prevention (China CDC), China became the first country to incorporate Treatment as Prevention as part of its national HIV/AIDS strategy to control HIV/AIDS over the next five years.
For all latest news, follow The Daily Star's Google News channel.
Comments